Mingzhu Logistics Receives Nasdaq Delisting Notice,Plans Further Appeal
Globenewswire· 2025-12-11 14:28
Core Points - Mingzhu Logistics Holdings Limited announced that its securities will be delisted from the Nasdaq Capital Market, with trading suspended on December 12, 2025 [1][4] - The delisting is due to non-compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1 per share for 30 consecutive business days [2] - The company was not eligible for the typical 180-calendar day cure period due to a Discretionary Panel Monitor imposed on May 20, 2025 [3] - The company intends to file an appeal with the Nasdaq Listing and Hearing Review Council within 15 days, although this will not prevent the scheduled suspension of trading [4] - Following the Nasdaq suspension, trading liquidity may become extremely limited, and the company expects its securities to be quoted in the Over-the-Counter (OTC) market [5] Company Overview - Mingzhu Logistics Holdings Limited, established in 2002 and headquartered in Shenzhen, China, is a 4A-rated professional trucking service provider [6] - The company offers tailored logistics solutions through a combination of self-owned fleets and subcontractors' fleets, focusing on regional logistics in Guangdong Province [6]
Diginex Appoints Lorenzo Romano as Deputy Chairman Amid Booming Sustainability RegTech Market Opportunity
Globenewswire· 2025-12-11 14:25
Core Insights - Diginex Limited has appointed Lorenzo Romano as Deputy Chairman to enhance governance and capitalize on the growing sustainability RegTech market, projected to expand from approximately $20 billion in 2025 to over $80 billion by 2032 due to increasing ESG regulations and demand for compliance technologies [1][3]. Company Developments - Mr. Romano, who previously served as Head of M&A and Strategic Development, has played a crucial role in advancing Diginex's acquisition strategy and integrating Matter DK ApS, contributing to initiatives like the recent acquisition MOUs with Matter and Plan A [2][5]. - His extensive experience in private banking and corporate development, including senior roles at EFG Bank and Syz Bank, positions him to guide Diginex through transformative growth phases in the sustainability RegTech sector [4][5]. Strategic Focus - In his new role, Mr. Romano will enhance corporate governance, strategic planning, and continue to drive the M&A agenda, ensuring alignment between long-term objectives and operational execution [5][6]. - Diginex aims to lead in the sustainability RegTech sector by providing innovative tools for navigating stringent global regulations, leveraging platforms like diginexESG and diginexLUMEN for ESG compliance and supply chain monitoring [6][7]. Market Context - The increasing global demand for robust sustainability solutions is driven by regulatory frameworks such as the EU's Corporate Sustainability Reporting Directive (CSRD), prompting companies to seek specialized RegTech platforms for efficient management of reporting and compliance [3][6].
The Honest Company to Participate in Northland Growth Conference 2025 – December 16, 2025
Globenewswire· 2025-12-11 14:25
Core Insights - The Honest Company is participating in the Northland Growth Conference 2025, with key executives attending to engage with investors [1] Company Overview - The Honest Company, listed on NASDAQ as HNST, focuses on creating cleanly-formulated and sustainably-designed personal care products across various categories including diapers, wipes, baby personal care, beauty, apparel, household care, and wellness [2] - Founded in 2012, the company aims to challenge traditional ingredients and industry standards through its Honest brand and mission [2]
Imperial Petroleum Inc. Reports Third Quarter and Nine Months 2025 Financial and Operating Results
Globenewswire· 2025-12-11 14:20
ATHENS, Greece, Dec. 11, 2025 (GLOBE NEWSWIRE) -- IMPERIAL PETROLEUM INC. (NASDAQ: IMPP; the “Company”), a ship-owning company providing petroleum products, crude oil and dry bulk seaborne transportation services, announced today its unaudited financial and operating results for the third quarter and nine months ended September 30, 2025. OPERATIONAL AND FINANCIAL HIGHLIGHTS Full integration of our seven drybulk vessels within Q3 25’ leading to a 36.1% increase of fleet calendar days compared to Q2 25’.Fleet ...
Winners Inc. Announces Completion of Acquisition of Moneyline Sports Inc., And Provides Year End Letter To Shareholders
Globenewswire· 2025-12-11 14:18
LAS VEGAS, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Winners, Inc., (OTC: WNRS), a Company that provides predictive sports analytics and data products driven by Gen AI for US sports, including NFL, NBA, MLB, and NCAA to predictive markets Polymarket and Kalshi, today announced the completion of acquisition of Moneyline Sports Inc. and provided the following year end Letter To Shareholders from the new Winners Inc. CEO, Michael Friedman. Dear Shareholders, As we move toward the year end of 2025, I am honored to intr ...
Agencia Comercial Spirits Ltd Announces Additions to Board of Directors
Globenewswire· 2025-12-11 14:18
Taichung City, Taiwan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Agencia Comercial Spirits Ltd (the “Company” or “Agencia”) (NASDAQ: AGCC), a Taiwan-based specialized importer and distributor of high-quality whiskies in Taiwan and international markets, today announced changes to its board of directors (the “Board”). Agencia announced that it has increased the size of its Board by two (2), bringing the total number of directors to seven (7). The Company also announced the appointment of Li Qiang as an Executive Dir ...
Reliance Global Group Enters Into Letter of Intent to Sell U.S. Benefits Alliance/EBS Business Unit; Expects Closing Within 30 Days
Globenewswire· 2025-12-11 14:15
Transaction Expected to Enhance Financial Flexibility; 50% of Net Proceeds to Further Reduce DebtLAKEWOOD, NJ, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance,” “we,” “us,” “our” or the “Company”) today announced that it has entered into a non-binding letter of intent to sell its two subsidiaries, U.S. Benefits Alliance, LLC and Employee Benefits Solutions, LLC (together, “EBS”), two non-core agencies located in Cadillac, Michigan. The agreement is subject to executio ...
Cemtrex, Inc. Announces $2 Million Registered Direct Offering
Globenewswire· 2025-12-11 14:15
Hauppauge, NY, Dec. 11, 2025 (GLOBE NEWSWIRE) -- -- Cemtrex, Inc. (NASDAQ: CETX) (the “Company”), an advanced security technology and industrial services company, today announced that it has entered into a definitive agreement for the purchase of approximately 666,667 shares with a single institutional investor, at a purchase price of $3 per share, with gross proceeds to the Company expected to be $2 million to the Company. The transaction is expected to close on or about Dec 11, 2025, subject to the satisf ...
Cycurion, Inc. (NASDAQ: CYCU) Announces Updated Dividend Distribution Ratio of 0.0180 in Connection with the Previously Announced $500,000 Common Share Dividend to Be Paid on or about December 30th
Globenewswire· 2025-12-11 14:15
MCLEAN, Va., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”) today announced that, as a result of the terms contained in certain securities issued in connection with the previously announced private placement on December 5, 2025 and certain outstanding securities of the Company, it is updating the dividend distribution ratio to 0.0180 CYCU common shares for every existing CYCU common share (on a fully diluted basis) held as of the record date, or December 15, 20 ...
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
Globenewswire· 2025-12-11 14:15
Core Viewpoint - GRI Bio, Inc. has announced a public offering of 10,666,667 shares of common stock and Series F warrants, aiming to raise approximately $8 million for product development and general corporate purposes [1][3]. Company Overview - GRI Bio is a clinical-stage biopharmaceutical company focused on treating inflammatory, fibrotic, and autoimmune diseases through Natural Killer T (NKT) cell modulators [6]. - The company's lead program, GRI-0621, is an inhibitor of iNKT cell activity, targeting idiopathic pulmonary fibrosis, a disease with significant unmet medical needs [6]. - GRI Bio is also developing a pipeline of novel type 2 diverse NKT (dNKT) agonists for systemic lupus erythematosus and has a library of over 500 proprietary compounds to support its pipeline [6]. Offering Details - The public offering is priced at $0.75 per share, with Series F warrants exercisable at the same price, expiring five years after issuance [1]. - The offering is expected to close around December 12, 2025, pending customary closing conditions [1]. - H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering [2]. Financial Implications - The gross proceeds from the offering are anticipated to be approximately $8 million before deducting fees and expenses [3]. - If fully exercised, the Series F warrants could provide an additional $8 million in gross proceeds [3].